634 Transitioning From Vedolizumab IV to Vedolizumab SC in Patients With Ulcerative Colitis: Results From the VISIBLE Program - Wolf, D; Danese, S; Matthews, B (Official journal of the American College of Gastroenterology | ACG, 2019)
et al.